Autopsy report · NCT00681668

Quetiapine in Postpartum Depression

“Recruitment behind plan, no increase expected”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 1 year 2 months before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 1 year 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

AstraZeneca

Sponsor type

Industry

Conditions

Postpartum Depressive Disorder

Interventions

Quetiapine

Participants

5

Sites

1

Countries

Germany

Trials that died the same way

• QuiremSpheres Observational Study
  “did not meet planned recruitment expectations with a slow recruitment rate” (72% match in meaning)
• Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
  “Recruitment too low” (70% match in meaning)
• Return to Work and Living Healthy After Head and Neck Cancer
  “insufficient recruitment rate” (70% match in meaning)
• Aspirin to Target Arterial Events in Chronic Kidney Disease
  “Planned recruitment total was not achievable within the funded timeframe” (70% match in meaning)
• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.